金吾财讯 | West Pharmaceutical（WST）盘前股价大幅上扬，报303.37美元，涨10.55%。
消息面上，West Pharmaceutical发布一季度财报，各项核心数据均大幅超出市场预期。一季度公司营收8.449亿美元，同比增长21.0%；非GAAP每股收益2.13美元，超出预期0.45美元。当期稀释每股收益1.92美元，同比增长56.1%，调整后稀释每股收益2.13美元，同比增长46.9%。现金流方面，经营现金流8990万美元，资本支出4270万美元，自由现金流4720万美元。公司当期完成股票回购，以均价243.57美元累计回购120万股，耗资2.976亿美元。
公司同步上调全年及二季度业绩展望。2026全年净销售额、调整后每股收益预期均大幅上调，均高于市场预期；二季度净销售额预计8.3亿至8.5亿美元，销售额同比增速8.3%-10.9%，有机增速7.0%-9.6%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.